Harper Vansteenhouse

Harper brings a broad set of commercial and operational skills to the team – a formally trained developmental neuroscientist who is as comfortable with cell biology and platform technology development as he is with understanding customer pain points, addressing regulatory requirements, and managing partner relationships. Harper particularly enjoys the pace of early-stage startups, leveraging his unique insights in strategic, financial, marketing and operations to make an impact on customer and company success.

After receiving his PhD in Neuroscience from University of California, San Diego, Harper assumed multiple commercial and leadership roles in cutting-edge life science and diagnostics companies, such as Illumina, Fluidigm, BioNano Genomics, and BioClavis. During the covid pandemic, Harper also served as Site Director at the UKHSA Lighthouse high-throughput RT-PCR lab, building the Glasgow lab to 105,000 test per day capacity. Harper is also a member of the editorial board of the Cambridge Press Journal: Precision Medicine.